Literature DB >> 17727568

GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii.

E Jongert1, S de Craeye, J Dewit, K Huygen.   

Abstract

In a previous study, single-gene vaccination with GRA1, GRA7 or ROP2 was shown to elicit partial protection against Toxoplasma gondii. In this study, the contribution of each antigen in the evoked humoral and cellular immune responses was evaluated after vaccination with plasmid mixtures containing GRA1, GRA7 and ROP2. Cocktail DNA vaccinated mice developed high antibody titers against the antigens from two-gene DNA vaccine cocktails, but lower titres when immunized with the three-gene cocktail. High numbers of IFN-gamma secreting splenocytes were generated predominantly against GRA7. Brain cyst burden was reduced by 81% in mice vaccinated with the three-gene mixture and they were completely protected against acute toxoplasmosis. Similar high levels of brain cyst reductions were obtained after vaccination with cocktails composed of GRA1 and GRA7 (89% reduction), or GRA7 and ROP2 (79% reduction), but not with the cocktail composed of GRA1 and ROP2. In low dose single-gene vaccinations, IFN-gamma and strong protection could only be elicited by GRA7. Hence, the presence of GRA7 in the DNA vaccine formulation was important for optimal protection and this was correlated with GRA7-specific IFN-gamma production. We propose GRA7 as a main component in cocktail DNA vaccines for vaccination against T. gondii.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17727568     DOI: 10.1111/j.1365-3024.2007.00961.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  17 in total

1.  Bioinformatics analysis of single and multi-hybrid epitopes of GRA-1, GRA-4, GRA-6 and GRA-7 proteins to improve DNA vaccine design against Toxoplasma gondii.

Authors:  Minoo Shaddel; Mansour Ebrahimi; Mohammad Reza Tabandeh
Journal:  J Parasit Dis       Date:  2018-04-17

2.  Toxoplasma gondii-positive human sera recognise intracellular tachyzoites and bradyzoites with diverse patterns of immunoreactivity.

Authors:  Marijo S Roiko; Kaice LaFavers; Diane Leland; Gustavo Arrizabalaga
Journal:  Int J Parasitol       Date:  2017-11-21       Impact factor: 3.981

3.  Induction of protective immune responses by a multiantigenic DNA vaccine encoding GRA7 and ROP1 of Toxoplasma gondii.

Authors:  Juan-Hua Quan; Jia-Qi Chu; Hassan Ahmed Hassan Ahmed Ismail; Wei Zhou; Eun-Kyeong Jo; Guang-Ho Cha; Young-Ha Lee
Journal:  Clin Vaccine Immunol       Date:  2012-03-14

Review 4.  REVIEW OF DNA VACCINE APPROACHES AGAINST THE PARASITE TOXOPLASMA GONDII.

Authors:  Rosalie C Warner; Ryan C Chapman; Brianna N Davis; Paul H Davis
Journal:  J Parasitol       Date:  2021-11-01       Impact factor: 1.276

5.  Toxoplasma gondii: immune response and protective efficacy induced by ROP16/GRA7 multicomponent DNA vaccine with a genetic adjuvant B7-2.

Authors:  Qi Liu; Fuwu Wang; Guan Wang; Qunli Zhao; Juan Min; Shuai Wang; Hua Cong; Ying Li; Shenyi He; Huaiyu Zhou
Journal:  Hum Vaccin Immunother       Date:  2013-10-07       Impact factor: 3.452

6.  Differential regulation of effector- and central-memory responses to Toxoplasma gondii Infection by IL-12 revealed by tracking of Tgd057-specific CD8+ T cells.

Authors:  Douglas C Wilson; Gijsbert M Grotenbreg; Kenian Liu; Yanlin Zhao; Eva-Maria Frickel; Marc-Jan Gubbels; Hidde L Ploegh; George S Yap
Journal:  PLoS Pathog       Date:  2010-03-19       Impact factor: 6.823

7.  GRA2 and ROP1 recombinant antigens as potential markers for detection of Toxoplasma gondii-specific immunoglobulin G in humans with acute toxoplasmosis.

Authors:  Lucyna Holec-Gasior; Józef Kur; Elzbieta Hiszczyńska-Sawicka
Journal:  Clin Vaccine Immunol       Date:  2009-02-18

8.  Protective immune response in BALB/c mice induced by DNA vaccine of the ROP8 gene of Toxoplasma gondii.

Authors:  Sonaimuthu Parthasarathy; Mun Yik Fong; Kalyanasundaram Ramaswamy; Yee Ling Lau
Journal:  Am J Trop Med Hyg       Date:  2013-03-18       Impact factor: 2.345

9.  Effectiveness of a novel immunogenic nanoparticle platform for Toxoplasma peptide vaccine in HLA transgenic mice.

Authors:  Kamal El Bissati; Ying Zhou; Debleena Dasgupta; Drew Cobb; Jitender P Dubey; Peter Burkhard; David E Lanar; Rima McLeod
Journal:  Vaccine       Date:  2014-04-13       Impact factor: 3.641

10.  Multicomponent DNA vaccine-encoding Toxoplasma gondii GRA1 and SAG1 primes: anti-Toxoplasma immune response in mice.

Authors:  Xiao-Nan Wu; Jie Lin; Xu Lin; Jie Chen; Zhong-Long Chen; Jian-Yin Lin
Journal:  Parasitol Res       Date:  2012-07-27       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.